News
![3 Dividend Stocks That Still Make Sense in 2023: https://www.marketbeat.com/logos/articles/med_20230717061732_3-dividend-stocks-that-still-make-sense-in-2023.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBM0pRYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--b09c21eed27bad96eec4640bb14a3230dc101d64/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20230717061732_3-dividend-stocks-that-still-make-sense-in-2023.jpg?locale=us)
3 Dividend Stocks That Still Make Sense in 2023
It was hard to find big stock market winners in 2022. But dividend stocks were among the better performers. Dividend-paying stocks give investors a reward for simply holding on to the stock. That
![United Health Stock Is Flying, It May Only Be The Beginning: https://www.marketbeat.com/logos/articles/med_20230714140747_united-health-stock-is-flying-it-may-only-be-the-b.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBM1JRYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--4d36d13b71836b7b38858c8bb9fdcd3f45ee1e20/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20230714140747_united-health-stock-is-flying-it-may-only-be-the-b.jpg?locale=us)
United Health Stock Is Flying, It May Only Be The Beginning
The United States Economy is beginning to undergo a significant pivot, where specific industries will be rewarded with investment inflows over others. As the FED attempts to combat rampant inflation
![United Health Stock Is Flying, It May Only Be The Beginning: https://www.marketbeat.com/logos/articles/med_20230714140747_united-health-stock-is-flying-it-may-only-be-the-b.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBM1JRYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--4d36d13b71836b7b38858c8bb9fdcd3f45ee1e20/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20230714140747_united-health-stock-is-flying-it-may-only-be-the-b.jpg?locale=us)
United Health Stock Is Flying, It May Only Be The Beginning
The United States Economy is beginning to undergo a significant pivot, where specific industries will be rewarded with investment inflows over others. As the FED attempts to combat rampant inflation
![Investors Like Adobe's Potential To Leverage Generative AI: https://www.marketbeat.com/logos/articles/med_20230714053821_investors-like-adobes-potential-to-leverage-genera.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBM1ZRYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--3b88c5156cd95ca85ec26363a7e2b574761cc23e/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20230714053821_investors-like-adobes-potential-to-leverage-genera.jpg?locale=us)
Investors Like Adobe's Potential To Leverage Generative AI
A few decades ago, a comedian named Murray Langston made a splash with an alter ego he dubbed “the unknown comic.” Langson was funny, but nobody knew who he was, since he performed with a bag over
![Investors Like Adobe's Potential To Leverage Generative AI: https://www.marketbeat.com/logos/articles/med_20230714053821_investors-like-adobes-potential-to-leverage-genera.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBM1ZRYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--3b88c5156cd95ca85ec26363a7e2b574761cc23e/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20230714053821_investors-like-adobes-potential-to-leverage-genera.jpg?locale=us)
Investors Like Adobe's Potential To Leverage Generative AI
A few decades ago, a comedian named Murray Langston made a splash with an alter ego he dubbed “the unknown comic.” Langson was funny, but nobody knew who he was, since he performed with a bag over
![Investors Like Adobe's Potential To Leverage Generative AI: https://www.marketbeat.com/logos/articles/med_20230714053821_investors-like-adobes-potential-to-leverage-genera.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBM1ZRYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--3b88c5156cd95ca85ec26363a7e2b574761cc23e/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20230714053821_investors-like-adobes-potential-to-leverage-genera.jpg?locale=us)
Investors Like Adobe's Potential To Leverage Generative AI
A few decades ago, a comedian named Murray Langston made a splash with an alter ego he dubbed “the unknown comic.” Langson was funny, but nobody knew who he was, since he performed with a bag over
![Eilt: 20% der Hautkrebs-Patienten vollständig geheilt - Massives Kaufsignal. Neuer 204% Biotech Hot Stock nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB). : https://www.irw-press.at/prcom/images/messages/2023/71350/AC-170723.001.png](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBeXBRYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--206c5d6d311d0708c667fd826dd1799cc6a956b8/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/AC-170723.001.png?locale=us)
Eilt: 20% der Hautkrebs-Patienten vollständig geheilt - Massives Kaufsignal. Neuer 204% Biotech Hot Stock nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB).
20% der Hautkrebs-Patienten vollständig geheilt - Massives Kaufsignal. 204% Biotech Hot Stock nach 134.452% mit Biogen
17.07.23 08:03
London (www.aktiencheck.de , Anzeige)
![Eilt: 20% der Hautkrebs-Patienten vollständig geheilt - Massives Kaufsignal. Neuer 204% Biotech Hot Stock nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB). : https://www.irw-press.at/prcom/images/messages/2023/71350/AC-170723.001.png](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBeXBRYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--206c5d6d311d0708c667fd826dd1799cc6a956b8/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/AC-170723.001.png?locale=us)
Eilt: 20% der Hautkrebs-Patienten vollständig geheilt - Massives Kaufsignal. Neuer 204% Biotech Hot Stock nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB).
20% der Hautkrebs-Patienten vollständig geheilt - Massives Kaufsignal. 204% Biotech Hot Stock nach 134.452% mit Biogen
17.07.23 08:03
London (www.aktiencheck.de , Anzeige)
![Eilt: 20% der Hautkrebs-Patienten vollständig geheilt - Massives Kaufsignal. Neuer 204% Biotech Hot Stock nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB). : https://www.irw-press.at/prcom/images/messages/2023/71350/AC-170723.001.png](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBeXBRYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--206c5d6d311d0708c667fd826dd1799cc6a956b8/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/AC-170723.001.png?locale=us)
Eilt: 20% der Hautkrebs-Patienten vollständig geheilt - Massives Kaufsignal. Neuer 204% Biotech Hot Stock nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB).
20% der Hautkrebs-Patienten vollständig geheilt - Massives Kaufsignal. 204% Biotech Hot Stock nach 134.452% mit Biogen
17.07.23 08:03
London (www.aktiencheck.de , Anzeige)
![Investing in Blue Chip Stocks: A Guide to Stability and Growth: https://www.marketbeat.com/logos/articles/med_20240716093219_investing-in-blue-chip-stocks-a-guide-to-stability.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBNlRXYkE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--de621f6a14d7a279a48c86678267cf2b1336cbdb/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20240716093219_investing-in-blue-chip-stocks-a-guide-to-stability.jpg?locale=us)
Investing in Blue Chip Stocks: A Guide to Stability and Growth
Investors who are looking for stability and steady growth often turn toward blue chip stocks. Blue chip stocks are shares in large, well-established companies with a history of reliable performance
![Investing in Blue Chip Stocks: A Guide to Stability and Growth: https://www.marketbeat.com/logos/articles/med_20240716093219_investing-in-blue-chip-stocks-a-guide-to-stability.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBNlRXYkE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--de621f6a14d7a279a48c86678267cf2b1336cbdb/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20240716093219_investing-in-blue-chip-stocks-a-guide-to-stability.jpg?locale=us)
Investing in Blue Chip Stocks: A Guide to Stability and Growth
Investors who are looking for stability and steady growth often turn toward blue chip stocks. Blue chip stocks are shares in large, well-established companies with a history of reliable performance
![Investing in Blue Chip Stocks: A Guide to Stability and Growth: https://www.marketbeat.com/logos/articles/med_20240716093219_investing-in-blue-chip-stocks-a-guide-to-stability.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBNlRXYkE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--de621f6a14d7a279a48c86678267cf2b1336cbdb/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20240716093219_investing-in-blue-chip-stocks-a-guide-to-stability.jpg?locale=us)
Investing in Blue Chip Stocks: A Guide to Stability and Growth
Investors who are looking for stability and steady growth often turn toward blue chip stocks. Blue chip stocks are shares in large, well-established companies with a history of reliable performance
![Investing in Blue Chip Stocks: A Guide to Stability and Growth: https://www.marketbeat.com/logos/articles/med_20240716093219_investing-in-blue-chip-stocks-a-guide-to-stability.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBNlRXYkE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--de621f6a14d7a279a48c86678267cf2b1336cbdb/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20240716093219_investing-in-blue-chip-stocks-a-guide-to-stability.jpg?locale=us)
Investing in Blue Chip Stocks: A Guide to Stability and Growth
Investors who are looking for stability and steady growth often turn toward blue chip stocks. Blue chip stocks are shares in large, well-established companies with a history of reliable performance
![Wells Fargo's Earnings, Why Markets Are Loving The Stock: https://www.marketbeat.com/logos/articles/med_20230714113126_wells-fargos-earnings-why-markets-are-loving-the-s.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBekZQYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--9026074cf12ad961b47c666e2c1cc69fa7bb506e/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20230714113126_wells-fargos-earnings-why-markets-are-loving-the-s.jpg?locale=us)
Wells Fargo's Earnings, Why Markets Are Loving The Stock
The SPDR S&P 500 ETF Trust (NYSEARCA: SPY) has been trading within a tight channel during the past year, hovering between the $420 and $375 per share marks. This trading range could be seen as
![Citigroup Leads Banking Earnings, What's Next?: https://www.marketbeat.com/logos/articles/med_20230714094250_cititechs.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBeXBQYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--791f76937bb319b60c453814ebca72481f6b0bdd/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20230714094250_cititechs.jpg?locale=us)
Citigroup Leads Banking Earnings, What's Next?
Not too long ago, commercial and investment banks passed the annual FED 'stress test,' where banks are under the heat of liquidity and leverage scrutiny. The leading United States firms passed
![BlackRock Kicks Off Financials Earnings Season, Gauge To Markets: https://www.marketbeat.com/logos/articles/med_20230714091740_blackrock-kicks-off-financials-earnings-season-gau.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBeHBQYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--6822b421d2baef1fec41bfaa571b8f4215d51a33/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20230714091740_blackrock-kicks-off-financials-earnings-season-gau.jpg?locale=us)
BlackRock Kicks Off Financials Earnings Season, Gauge To Markets
A new earnings season is beginning to kick off, bringing on periods of increased volatility and opportunity to investors as long as they position themselves within the favored industries and names
![JPMorgan Chase Is In Reversal But Don’t Chase It Higher: https://www.marketbeat.com/logos/articles/med_20230714081700_copy-1-of-chart-jpm-7142023.png](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBd1pQYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--0d816cd82b838d7d0a1977f40fb03bdb9caf947e/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20230714081700_copy-1-of-chart-jpm-7142023.png?locale=us)
JPMorgan Chase Is In Reversal But Don’t Chase It Higher
The price action in JPMorgan Chase & Company (NYSE: JPM) has been bullish all year. The prospect of higher interest rates, widening margins, and increased earnings have helped to drive the market
![JPMorgan Chase Is In Reversal But Don’t Chase It Higher: https://www.marketbeat.com/logos/articles/med_20230714081700_copy-1-of-chart-jpm-7142023.png](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBd1pQYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--0d816cd82b838d7d0a1977f40fb03bdb9caf947e/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20230714081700_copy-1-of-chart-jpm-7142023.png?locale=us)
JPMorgan Chase Is In Reversal But Don’t Chase It Higher
The price action in JPMorgan Chase & Company (NYSE: JPM) has been bullish all year. The prospect of higher interest rates, widening margins, and increased earnings have helped to drive the market
![Fastenal Falls To The Buy Zone: But Wait To Buy More: https://www.marketbeat.com/logos/articles/med_20230714073323_chart-fast-7142023.png](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBL1ZPYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--e7f863a443c3fbd4877485fbe6b29c7efe2f2dbe/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20230714073323_chart-fast-7142023.png?locale=us)
Fastenal Falls To The Buy Zone: But Wait To Buy More
Fastenal (NASDAQ: FAST) fell following its Q2 earnings release and could fall further. The caveat is that tepid results do not overshadow the company’s strengths, including a solid balance sheet
![Fastenal Falls To The Buy Zone: But Wait To Buy More: https://www.marketbeat.com/logos/articles/med_20230714073323_chart-fast-7142023.png](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBL1ZPYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--e7f863a443c3fbd4877485fbe6b29c7efe2f2dbe/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20230714073323_chart-fast-7142023.png?locale=us)
Fastenal Falls To The Buy Zone: But Wait To Buy More
Fastenal (NASDAQ: FAST) fell following its Q2 earnings release and could fall further. The caveat is that tepid results do not overshadow the company’s strengths, including a solid balance sheet
![Fastenal Falls To The Buy Zone: But Wait To Buy More: https://www.marketbeat.com/logos/articles/med_20230714073323_chart-fast-7142023.png](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBL1ZPYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--e7f863a443c3fbd4877485fbe6b29c7efe2f2dbe/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20230714073323_chart-fast-7142023.png?locale=us)
Fastenal Falls To The Buy Zone: But Wait To Buy More
Fastenal (NASDAQ: FAST) fell following its Q2 earnings release and could fall further. The caveat is that tepid results do not overshadow the company’s strengths, including a solid balance sheet
![Broadcom Emerges As Strong Contender For Generative AI Chips: https://www.marketbeat.com/logos/articles/med_20230714055530_broadcom-emerges-as-strong-contender-for-generativ.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBOVJPYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--d5bdd5c030fc55cb6137aa7f5113a4327f128e57/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20230714055530_broadcom-emerges-as-strong-contender-for-generativ.jpg?locale=us)
Broadcom Emerges As Strong Contender For Generative AI Chips
So far in the AI gold rush, Nvidia Corp. (NASDAQ: NVDA) has emerged as the leading chipmaker. However, analysts and investors are beginning to notice the potential for Broadcom Inc. (NASDAQ: AVGO)
![Broadcom Emerges As Strong Contender For Generative AI Chips: https://www.marketbeat.com/logos/articles/med_20230714055530_broadcom-emerges-as-strong-contender-for-generativ.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBOVJPYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--d5bdd5c030fc55cb6137aa7f5113a4327f128e57/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20230714055530_broadcom-emerges-as-strong-contender-for-generativ.jpg?locale=us)
Broadcom Emerges As Strong Contender For Generative AI Chips
So far in the AI gold rush, Nvidia Corp. (NASDAQ: NVDA) has emerged as the leading chipmaker. However, analysts and investors are beginning to notice the potential for Broadcom Inc. (NASDAQ: AVGO)
![Broadcom Emerges As Strong Contender For Generative AI Chips: https://www.marketbeat.com/logos/articles/med_20230714055530_broadcom-emerges-as-strong-contender-for-generativ.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBOVJPYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--d5bdd5c030fc55cb6137aa7f5113a4327f128e57/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20230714055530_broadcom-emerges-as-strong-contender-for-generativ.jpg?locale=us)
Broadcom Emerges As Strong Contender For Generative AI Chips
So far in the AI gold rush, Nvidia Corp. (NASDAQ: NVDA) has emerged as the leading chipmaker. However, analysts and investors are beginning to notice the potential for Broadcom Inc. (NASDAQ: AVGO)
![Deep Value Conagra Brands Pulls Into The Buy Zone: https://www.marketbeat.com/logos/articles/med_20230713123111_chart-cag-7132023.png](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBOWxPYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--58ec2fa62a58ea6a977957877bf4b6483db58c8f/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20230713123111_chart-cag-7132023.png?locale=us)
Deep Value Conagra Brands Pulls Into The Buy Zone
Conagra Brands (NASDAQ: CAG) isn’t leading the consumer staples sector but is a leading candidate for new investment. The company’s struggles have the share prices trading near multi-year lows and